These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8973750)
1. Comparison of cholinergic vasodilator responses to acetylcholine and methacholine in the human forearm. Bruning TA; Chang PC; Kemme MJ; Vermeij P; Pfaffendorf M; van Zwieten PA Blood Press; 1996 Nov; 5(6):333-41. PubMed ID: 8973750 [TBL] [Abstract][Full Text] [Related]
2. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans. Rongen GA; Smits P; Thien T J Cardiovasc Pharmacol; 1993 Dec; 22(6):884-8. PubMed ID: 7509909 [TBL] [Abstract][Full Text] [Related]
3. Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor. Bruning TA; Chang PC; Blauw GJ; Vermeij P; van Zwieten PA J Cardiovasc Pharmacol; 1993 Jul; 22(1):44-51. PubMed ID: 7690095 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm. Kamper AM; Paul LC; Blauw GJ J Cardiovasc Pharmacol; 2002 Dec; 40(6):922-9. PubMed ID: 12451326 [TBL] [Abstract][Full Text] [Related]
5. Is nitric oxide involved in cutaneous vasodilation during body heating in humans? Dietz NM; Rivera JM; Warner DO; Joyner MJ J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431 [TBL] [Abstract][Full Text] [Related]
6. Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Chowienczyk PJ; Cockcroft JR; Ritter JM Br J Pharmacol; 1993 Oct; 110(2):736-8. PubMed ID: 8242245 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of acetylcholinesterase selectively potentiates NG-monomethyl-L-arginine-resistant actions of acetylcholine in human forearm vasculature. Chowienczyk PJ; Cockcroft JR; Ritter JM Clin Sci (Lond); 1995 Jan; 88(1):111-7. PubMed ID: 7704991 [TBL] [Abstract][Full Text] [Related]
8. Role of nitric oxide in methacholine-induced sweating and vasodilation in human skin. Lee K; Mack GW J Appl Physiol (1985); 2006 Apr; 100(4):1355-60. PubMed ID: 16239618 [TBL] [Abstract][Full Text] [Related]
9. Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle. Schrage WG; Dietz NM; Eisenach JH; Joyner MJ J Appl Physiol (1985); 2005 Apr; 98(4):1251-7. PubMed ID: 15563630 [TBL] [Abstract][Full Text] [Related]
10. Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide. Newby DE; Boon NA; Webb DJ Clin Sci (Lond); 1997 Feb; 92(2):133-8. PubMed ID: 9059313 [TBL] [Abstract][Full Text] [Related]
11. Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation. Duffy SJ; New G; Harper RW; Meredith IT Cardiovasc Res; 1999 Aug; 43(3):721-30. PubMed ID: 10690343 [TBL] [Abstract][Full Text] [Related]
12. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193 [TBL] [Abstract][Full Text] [Related]
13. Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. Chin-Dusting JP; Alexander CT; Arnold PJ; Hodgson WC; Lux AS; Jennings GL J Cardiovasc Pharmacol; 1996 Jul; 28(1):158-66. PubMed ID: 8797150 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous blood flow and sweat rate responses to exogenous administration of acetylcholine and methacholine. Kimura K; Low DA; Keller DM; Davis SL; Crandall CG J Appl Physiol (1985); 2007 May; 102(5):1856-61. PubMed ID: 17234802 [TBL] [Abstract][Full Text] [Related]
15. Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Noon JP; Walker BR; Hand MF; Webb DJ Br J Clin Pharmacol; 1998 Jun; 45(6):545-50. PubMed ID: 9663809 [TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Bruning TA; Hendriks MG; Chang PC; Kuypers EA; van Zwieten PA Circ Res; 1994 May; 74(5):912-9. PubMed ID: 8156638 [TBL] [Abstract][Full Text] [Related]
17. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine. Schlaich MP; Ahlers BA; Parnell MM; Kaye DM J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763 [TBL] [Abstract][Full Text] [Related]
18. Characterization of ATP-induced vasodilation in the human forearm vascular bed. Rongen GA; Smits P; Thien T Circulation; 1994 Oct; 90(4):1891-8. PubMed ID: 7923677 [TBL] [Abstract][Full Text] [Related]
19. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Dawes M; Chowienczyk PJ; Ritter JM Br J Pharmacol; 2001 Nov; 134(5):939-44. PubMed ID: 11682440 [TBL] [Abstract][Full Text] [Related]
20. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Lyons D; Roy S; Patel M; Benjamin N; Swift CG Clin Sci (Lond); 1997 Dec; 93(6):519-25. PubMed ID: 9497788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]